Catabasis Pharmaceuticals Reports First Quarter 2019 Financial Results and Reviews Business Progress
— Edasalonexent Phase 3 PolarisDMD Trial in Duchenne Muscular Dystrophy Enrolling Boys Globally — — Sustained Slowing of DMD Disease…
Pharmaceuticals, Biotechnology and Life Sciences
— Edasalonexent Phase 3 PolarisDMD Trial in Duchenne Muscular Dystrophy Enrolling Boys Globally — — Sustained Slowing of DMD Disease…
A fully managed cloud data hub that speeds up the drug discovery process and fuels the use of artificial intelligence…
Highly encouraging resistance profile of Company’s lead drug candidate to be presented at the 32nd International Conference on Antiviral Research…
Tolimidone treatment significantly reduced HbA1c compared to placebo Company makes strategic decision to move tolimidone into NASH development EXTON, Pa.–(BUSINESS…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cedilla Therapeutics today announced the appointment of Delphine Collin, Ph.D., as vice president, biomolecular sciences. In this role,…
WASHINGTON–(BUSINESS WIRE)–BioCompute, a collaboration between The George Washington University and the FDA to improve communication of bioinformatics pipelines, today announced…
Chief Technology Officer Recognized for Groundbreaking Titanium® Platform MORRISTOWN, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/NJBIZ?src=hash" target="_blank"gt;#NJBIZlt;/agt;–QPharma, a premier provider of commercial and compliance…
WOBURN, Mass.–(BUSINESS WIRE)–ReForm Biologics, a pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, today announced…
First quarter 2019 revenue increase of 45% over prior year Completion of go-public transaction provides capital to fund long-term growth…
First quarter 2019 revenue increase of 45% over prior year Completion of go-public transaction provides capital to fund long-term growth…